|
Volumn 135, Issue 3, 2002, Pages 589-599
|
A NO-releasing derivative of acetaminophen spares the liver by acting at several checkpoints in the Fas pathway
|
Author keywords
Acetaminophen; Cytokines; Fas; Fas ligand; Hepatitis B transgenic mice; Nitric oxide
|
Indexed keywords
ASPARTATE AMINOTRANSFERASE;
ENDOTOXIN;
FAS ANTIGEN;
FAS LIGAND;
HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE;
INTERLEUKIN 1BETA;
LIPOPOLYSACCHARIDE;
NCX 701;
NITRIC OXIDE;
PARACETAMOL;
PARACETAMOL DERIVATIVE;
TUMOR NECROSIS FACTOR ALPHA;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIGEN EXPRESSION;
ARTICLE;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
CHRONIC LIVER DISEASE;
DOSE RESPONSE;
DRUG METABOLISM;
DRUG OVERDOSE;
DRUG SAFETY;
DRUG STRUCTURE;
FEVER;
HEPATITIS B VIRUS;
LIVER NECROSIS;
LIVER PROTECTION;
LIVER TOXICITY;
MALE;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
ACETAMINOPHEN;
ANIMALS;
BODY TEMPERATURE;
CYTOKINES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FAS LIGAND PROTEIN;
LIVER;
MALE;
MEMBRANE GLYCOPROTEINS;
MICE;
MICE, INBRED BALB C;
MICE, INBRED C57BL;
MICE, TRANSGENIC;
NITRIC OXIDE;
NITRIC OXIDE DONORS;
RATS;
RATS, WISTAR;
RNA, MESSENGER;
|
EID: 0036181113
PISSN: 00071188
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.bjp.0704500 Document Type: Article |
Times cited : (44)
|
References (44)
|